Company profile
MiNK Therapeutics
Changing lives through living medicines.
- Industry
- Biotechnology Research
- Employees
- 31
- Headquarters
- Lexington, Massachusetts
- Founded
- 2017
- LinkedIn followers
- 7,234
- Office locations
- 1
MiNK Therapeutics company summary
MiNK Therapeutics is a company in the Biotechnology Research industry, headquartered in Lexington, Massachusetts, founded in 2017. On LinkedIn the company has around 31 employees and 7,234 followers. Its listed specialties include Living drugs, Adoptive Cell Therapy, T Cell Receptors (TCRs).
What technology does MiNK Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About MiNK Therapeutics
We are a clinical stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells are a distinct T cell population that combine durable memory responses with the rapid cytolytic features of natural killer (NK) cells. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells and suppress Graft versus Host Disease (GvHD). Our proprietary platform is designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery. As such, we believe that our approach represents a highly versatile application for therapeutic development in cancer and immune diseases. We have leveraged our platform and manufacturing capabilities to develop a wholly owned pipeline for both native and engineered iNKT cells.
Specialties
Where is MiNK Therapeutics located?
MiNK Therapeutics lists 1 location.
Compare companies similar to MiNK Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
MiNK Therapeutics minktherapeutics.com | Biotechnology Research | 31 | 2017 | Lexington, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about MiNK Therapeutics
What does MiNK Therapeutics do?
We are a clinical stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells are a distinct T cell population that combine durable memory responses with the rapid cytolytic features of natural killer (NK) cells. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells and suppress Graft versus Host Disease (GvHD). Our proprietary platform is designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery. As such, we believe that our approach represents a highly versatile application for therapeutic development in cancer and immune diseases. We have leveraged our platform and manufacturing capabilities to develop a wholly owned pipeline for both native and engineered iNKT cells.
How many employees does MiNK Therapeutics have?
MiNK Therapeutics has around 31 employees on LinkedIn.
Where is MiNK Therapeutics headquartered?
MiNK Therapeutics is headquartered in Lexington, Massachusetts.
When was MiNK Therapeutics founded?
MiNK Therapeutics was founded in 2017.
Build a lead list from companies like MiNK Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.